Aspira Pathlab & Diagnostics Ltd.BSE: ASPIRA

Aspira Pathlab & Diagnostics Ltd. Press Release Oct 01 2026

· Moneycontrol

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali

View Attachment

Earlier from Aspira Pathlab & Diagnostics

All Aspira Pathlab & Diagnostics news releases